Showing results (761-770 of 2,003) with videos related to
Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2007
Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscleJianping YeEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Blockade of chemokine-mediated tissue injury in lupus nephritisVolker Vielhauer, Hans-Joachim AndersEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseasesWilliam StohlEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Anti-interleukin-6 receptor antibody therapy in rheumatic diseasesHideko Nakahara, Norihiro NishimotoEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategyJun Akaogi, Toshiko Nozaki, Minoru Satoh, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Targeting vascular disease in systemic sclerosisOtylia Kowal-BieleckaEndocrine, Metabolic & Immune Disorders Drug Targets|June 1, 2010
Corticosteroids in sepsis: pathophysiological rationale and the selection of patientsJorge Ibrain Figueira Salluh, Fernando Augusto Bozza, André Miguel Japiassú, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|June 1, 2010
Toll-like receptors in sepsis: a tale still being toldHeraldo Possolo Souza, Thais Lima-Salgado, Luis Monteiro da Cruz NetoEndocrine, Metabolic & Immune Disorders Drug Targets|June 1, 2010
Mitochondrial dysfunction during sepsisLuciano Cesar Pontes AzevedoEndocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2010
Molecular determinants of the cardiometabolic phenotypeLisa de las Fuentes, Giovanni de Simone, Donna K Arnett, et al.Pageof 201